Inherited gene variation tied to high-risk pediatric leukemia
An inherited gene variation has been linked to a nearly fourfold increased risk of developing a pediatric acute lymphoblastic leukemia subtype that is associated with a poor outcome.
An inherited gene variation has been linked to a nearly fourfold increased risk of developing a pediatric acute lymphoblastic leukemia subtype that is associated with a poor outcome.
This fact sheet reviews cancer types, incidence and survival rates, causes, and current research related to childhood cancer.
A genetic link specific to risk for childhood leukemia has been identified for the first time, according to a new study.
Survival highest for patients with both surgery, radiation, but lowest in African-Americans.
Modifiable cardiovascular risk factors contribute to the development of major cardiac events in adult survivors of childhood cancer.
Proton therapy offered the optimal combination of target coverage and organ-sparing in a recent study involving children with high-risk neuroblastoma.
Children whose leukemia cells have amplification of a portion of chromosome 21 may require more aggressive treatment for acute lymphoblastic leukemia than children without this gene amplification, according to a recent study.
One of the first questions parents ask when a child is diagnosed with cancer is “Will my other children get cancer?” A new study suggests that the answer to that question depends on whether a family history of cancer exists.
Pediatric cancer patients whose central lines (central venous catheters) are used to treat them at home develop three times as many dangerous bloodstream infections from their devices compared with their hospitalized counterparts.
A considerable proportion of children with melanoma do not present with conventional ABCDE detection criteria.